Exagen Inc.
XGN
$3.35
$0.020.60%
| Weiss Ratings | XGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | XGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | XGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.14 | |||
| Price History | XGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 11.30% | |||
| 30-Day Total Return | -17.69% | |||
| 60-Day Total Return | -41.54% | |||
| 90-Day Total Return | 33.47% | |||
| Year to Date Total Return | 8.41% | |||
| 1-Year Total Return | 89.27% | |||
| 2-Year Total Return | 40.76% | |||
| 3-Year Total Return | -55.51% | |||
| 5-Year Total Return | -82.09% | |||
| 52-Week High % Change | -46.46% | |||
| 52-Week Low % Change | 156.09% | |||
| Price | XGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $6.22 | |||
| 52-Week Low Price | $1.30 | |||
| 52-Week Low Price (Date) | Apr 16, 2024 | |||
| 52-Week High Price (Date) | Dec 16, 2024 | |||
| Valuation | XGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 58.74M | |||
| Enterprise Value | 59.87M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.94 | |||
| Earnings Per Share Growth | -49.65% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.09 | |||
| Price/Book (Q) | 4.53 | |||
| Enterprise Value/Revenue (TTM) | 1.07 | |||
| Price | $3.35 | |||
| Enterprise Value/EBITDA (TTM) | -4.41 | |||
| Enterprise Value/EBIT | -3.89 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | XGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 18.25M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | XGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 760 560 1501 | |||
| Address | 1261 Liberty Way Vista, CA 92081 | |||
| Website | www.exagen.com | |||
| Country | United States | |||
| Year Founded | 2002 | |||
| Profitability | XGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -27.62% | |||
| Profit Margin | -30.36% | |||
| Management Effectiveness | XGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -18.42% | |||
| Return on Equity | -- | |||
| Income Statement | XGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 55.75M | |||
| Total Revenue (TTM) | 55.75M | |||
| Revenue Per Share | $3.05 | |||
| Gross Profit (TTM) | 32.78M | |||
| EBITDA (TTM) | -13.58M | |||
| EBIT (TTM) | -15.40M | |||
| Net Income (TTM) | -16.93M | |||
| Net Income Avl. to Common (TTM) | -16.93M | |||
| Total Revenue Growth (Q YOY) | -6.78% | |||
| Earnings Growth (Q YOY) | 7.15% | |||
| EPS Diluted (TTM) | -0.94 | |||
| EPS Diluted Growth (Q YOY) | 10.03% | |||
| Balance Sheet | XGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 22.04M | |||
| Cash Per Share (Q) | $1.21 | |||
| Total Current Assets (Q) | 35.56M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 12.87M | |||
| Current Ratio (Q) | 4.051 | |||
| Book Value Per Share (Q) | $0.73 | |||
| Total Assets (Q) | 43.61M | |||
| Total Current Liabilities (Q) | 8.78M | |||
| Total Debt (Q) | 23.74M | |||
| Total Liabilities (Q) | 30.74M | |||
| Total Common Equity (Q) | 12.87M | |||
| Cash Flow | XGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -453.00K | |||
| Cash from Financing (TTM) | -667.00K | |||
| Net Change in Cash (TTM) | -6.41M | |||
| Levered Free Cash Flow (TTM) | -1.69M | |||
| Cash from Operations (TTM) | -5.29M | |||
